A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
![OHE Report_Henderson et al](https://www.ohe.org/wp-content/uploads/2021/11/OHE-Report_Henderson-et-al._Multi-indication-Rare-Diseases-2-01.png)
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.